Wednesday, October 15th 2014
Dr. Petra Schneider,Blackfield AG, Germany
Computational analysis of human- and mouse-specific next-generation sequencing data in mixed tissue samples
Blackfield is a young biotechnology company supporting pharmaceuticalcompanies in developing targeted cancer drugs. We offer to derivegenetic tumor profiles from next-generation sequencing (NGS) data.Computational analysis of the raw sequencing data using proprietaryalgorithms is a key step in this process, due to the massive amount ofdata generated by NGS platforms. In this talk, I will outline thegeneration and analysis of NGS data, and I will present the novelstrategy we integrated recently in our computational analysis pipelineto deal with contaminated tumor samples. Artificial validation samplesdemonstrate in a controlled setting how this approach influencesmutation calling or gene expression analyses.
Colloquium coordinators are Prof.dr. M. Aiello (e-mail :
Prof.dr. M. Biehl (e-mail:
University of Groningen and University of Oldenburg (UOL) celebrate 40 years of collaboration in 2020. On 29 October 2020 (Festakt-date) the UG and the UOL will officially renew the partnership that they started 40 years ago. The anniversary will...
The COVID-19 restrictions have been tightened once again. To many staff members and students, this feels like a step backwards. We chatted with members of the Board of the University Jouke de Vries, Cisca Wijmenga and Hans Biemans about managerial...
Biological clocks have sizeable effects on the performance of elite athletes. This conclusion was drawn by chronobiologists from the University of Groningen after studying the times achieved by swimmers in four different Olympic Games. Shifting the...